NCT00710970 2022-01-24
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment
Baylor College of Medicine
Phase 2 Completed
Clinical Trials
3 trialsNCT03147196 2019-01-22
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Mayo Clinic
Phase 2 Withdrawn
NCT01050842 2017-03-23
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed